发明名称 SCALEABLE CANNABINOID TREATMENT REGIMINE AND MEDICINAL FORMULATIONS
摘要 The present invention administers a cannabinoid medication to a patient followed by observing one or more physiological responses in the patient during a first period of time when treating a medical condition. The cannabinoid medication may include one or more specific types of cannabinoids at an initial dosage level. In certain instances the cannabinoid dosage level in incremented over the first period of time. The dose of a cannabinoid corresponds to a mass of one or more cannabinoid types administered to the patient over a period of time, typically over a day. The cannabinoid treatment may be combined with one or more other methods for treating cancer, such as administering a chemotherapy agent, a KRAS inhibitor, or a CTLA-4 antigen. The present invention also includes a formulation of cannabinoid medications that span one or more ranges of milligram dosages of one or more cannabinoids in a set of formulary drugs.
申请公布号 US2016331720(A1) 申请公布日期 2016.11.17
申请号 US201514714222 申请日期 2015.05.15
申请人 Hospodor Andrew David 发明人 Hospodor Andrew David
分类号 A61K31/352;A61K45/06;A61K31/05 主分类号 A61K31/352
代理机构 代理人
主权项 1. A method for treating a medical condition, the method comprising: administering one or more cannabinoids to a patient according to a first treatment regimen to a patient, wherein a dosage of at least one of the one or more cannabinoids are increased over a first period of time; monitoring one or more pathological factors of the patient; and observing a pathological event corresponding to the one or more pathological factors, wherein the observed pathological event indicates that the medical condition is improving.
地址 Santa Cruz CA US